Verona Pharma Faces Financial Risks Amid Medicaid Rebate Program Compliance Challenges
PremiumCompany AnnouncementsVerona Pharma Faces Financial Risks Amid Medicaid Rebate Program Compliance Challenges
5d ago
Verona Pharma Reports Strong Q3 Launch for COPD Drug
Premium
Company Announcements
Verona Pharma Reports Strong Q3 Launch for COPD Drug
5d ago
Verona Pharma reports Q3 EPS (7c), consensus (50c)
Premium
The Fly
Verona Pharma reports Q3 EPS (7c), consensus (50c)
5d ago
Verona Pharma partners with Ritedose to deliver Ohtuvayre drug for COPD
PremiumThe FlyVerona Pharma partners with Ritedose to deliver Ohtuvayre drug for COPD
2M ago
Jefferies biotech analyst holds an analyst/industry conference call
Premium
The Fly
Jefferies biotech analyst holds an analyst/industry conference call
2M ago
Verona Pharma management to meet virtually with Piper Sandler
Premium
The Fly
Verona Pharma management to meet virtually with Piper Sandler
3M ago
Verona Pharma call volume above normal and directionally bullish
PremiumThe FlyVerona Pharma call volume above normal and directionally bullish
4M ago
Verona Pharma price target raised to $38 from $32 at Truist
Premium
The Fly
Verona Pharma price target raised to $38 from $32 at Truist
4M ago
Unusually active option classes on open June 27th
Premium
The Fly
Unusually active option classes on open June 27th
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100